San Diego, CA, United States of America

Suzanne Pritchett Benedict

USPTO Granted Patents = 5 

Average Co-Inventor Count = 7.6

ph-index = 4

Forward Citations = 65(Granted Patents)


Location History:

  • San Diego, CA (US) (2003)
  • Carlsbad, CA (US) (2005 - 2019)

Company Filing History:


Years Active: 2003-2019

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Suzanne Pritchett Benedict: Innovator in Antibody Formulations and Protein Kinase Inhibitors

Introduction

Suzanne Pritchett Benedict is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of biotechnology, particularly in the development of antibody formulations and protein kinase inhibitors. With a total of 5 patents to her name, her work has the potential to impact the treatment of various diseases, including cancers and ophthalmologic disorders.

Latest Patents

One of her latest patents focuses on antibody formulations and their uses. This application relates to formulations of anti-CD105 antibodies and their antigen-binding fragments. It also discusses pre-filled syringes containing these formulations, which aim to reduce signs or symptoms of angiogenesis-related disorders. Another notable patent involves tricyclic compounds that act as protein kinase inhibitors. These compounds are designed to enhance the efficacy of anti-neoplastic agents and radiation therapy, providing a promising avenue for treating cancers.

Career Highlights

Throughout her career, Suzanne has worked with notable companies such as Agouron Pharmaceuticals, Inc. and Tracon Pharmaceuticals, Inc. Her experience in these organizations has allowed her to develop innovative solutions in the pharmaceutical industry.

Collaborations

Suzanne has collaborated with several professionals in her field, including Michael John Bennett and Sacha Ninkovic. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Suzanne Pritchett Benedict is a trailblazer in the field of biotechnology, with a focus on antibody formulations and protein kinase inhibitors. Her innovative work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…